FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Editorial, Typographical Corrections in Device Regs

Federal Register Final Rule; technical amendment: FDA amends certain medical device regulations to correct editorial issues, such as typographical err...

Human Drugs

Endo Agrees to Temporary Litigation Stay Extension

Endo agrees to extend for 180 days a stay in its suit against FDA over agency policy in compounding using bulk drug substances.

Medical Devices

Glucose Meter Benefits Outweigh Risks Panel Says

FDA panel members are divided on CLIA waivers for using glucose meters to measure blood glucose in capillary blood in patients receiving intensive med...

Human Drugs

FDA Celltrion Yeonsu-go Inspection Report Out

FDA releases the establishment inspection report from its 2017 inspection at the Celltrion Yeonsgu-go Plant 1 in Inchon, Korea.

Medical Devices

Gore Septal Occluder Expanded Approval

FDA approves a W. L. Gore expanded indication for its Gore Cardioform Septal Occluder for patent foramen ovale (PFO) closure to prevent recurrent isch...

Human Drugs

FDA Orders Recall of Triangle Kratom Products

FDA orders its first-ever mandatory recall for contaminated food products containing kratom manufactured by Triangle Pharmaceuticals.

Human Drugs

Companies Ask High Court to Hear Eye Drop Case

Drug companies ask the Supreme Court to determine whether consumers who say they lost money on prescription eye drops because the bottles dispense dru...

Federal Register

5 NDAs Withdrawn by FDA

Federal Register notice: FDA withdraws approval of five NDAs because the drug products are no longer marketed.

Human Drugs

Comments on FDA Drug Security Act Meetings

Stakeholders express appreciation for FDA public sessions on implementing the Drug Supply Chain Security Act and offer suggestions for improvements.

Human Drugs

Bydureon Expanded Use Approved as Insulin Add-on

FDA approves an AstraZeneca NDA for Bydureon (exenatide extended-release) for injectable suspension as an add-on therapy to basal insulin in adults wi...